Boardroom Alpha
Meeting calendar
BKKT · Special meeting · Tuesday, October 7, 2025

Bakkt Inc

6 nominees · 2 ballot items.

The special meeting will consider two proposals: the Options Proposal to approve a one-time grant of stock options to select management to purchase up to 7,450,000 shares of Class A Common Stock, and the Adjournment Proposal to authorize adjournment for additional proxies.

Market cap
$376M
1Y TSR
-32.9%
Board grade
C-
Record date
Sep 3, 2025
Filing
DEF 14A
Meeting concluded · Oct 7, 2025

Follow how the vote landed and what changed on Bakkt Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot2

  1. 1

    Approval of the Options Proposal

    ManagementBoard: FOR

    Approve a one-time grant of stock options to select members of management to purchase up to 7,450,000 shares of Class A Common Stock, intended to align management incentives with stockholders and support long-term value creation.

  2. 2

    Approval of the Adjournment Proposal

    ManagementBoard: FOR

    Approve adjournment of the Special Meeting if necessary or appropriate to solicit additional proxies to obtain sufficient votes for the Options Proposal.

Director elections

Nominees on the ballot6

Phillip Lord
Not independent
Tenure on this board
New nominee
Ownership

Top institutional holders10

Latest 13F quarter
1Alyeska Investment Group, L.P.2.3%1,023,810$8M
2Tidal Investments LLC2.1%947,547$7M
3Weiss Asset Management LP1.5%678,530$5M
4VANGUARD CAPITAL MANAGEMENT LLC1.4%623,335$5M
5BlackRock, Inc.1.3%598,283$4M
6LMR Partners LLP1.3%566,971$4M
7GEODE CAPITAL MANAGEMENT, LLC1.2%520,727$4M
8RENAISSANCE TECHNOLOGIES LLC1.0%441,100$3M
9BlackRock, Inc.0.9%405,158$3M
10CITADEL ADVISORS LLC0.8%367,087$3M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Bakkt Inc 2025 special meeting?
Bakkt Inc (BKKT) holds its 2025 special shareholder meeting on Tuesday, October 7, 2025.
What is the record date for the Bakkt Inc 2025 meeting?
The record date for the Bakkt Inc 2025 meeting is Wednesday, September 3, 2025. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Bakkt Inc's 2025 meeting?
The board is presenting 6 director nominees at the Bakkt Inc 2025 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Bakkt Inc 2025 meeting?
Shareholders will vote on 2 proposals at the Bakkt Inc 2025 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer